96 related articles for article (PubMed ID: 38498179)
1. [Primary sclerosing cholangitis-Diagnosis and treatment 2024].
Trauner M; Halilbasic E; Tatscher E; Fickert P
Inn Med (Heidelb); 2024 Apr; 65(4):347-356. PubMed ID: 38498179
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.
Eaton JE; Talwalkar JA; Lazaridis KN; Gores GJ; Lindor KD
Gastroenterology; 2013 Sep; 145(3):521-36. PubMed ID: 23827861
[TBL] [Abstract][Full Text] [Related]
3. [Excerpt from the 2022 American Association for the Study of Liver Diseases clinical practice guideline: management of primary sclerosing cholangitis and cholangiocarcinoma].
Yuan J; Han GH
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):35-41. PubMed ID: 36948847
[TBL] [Abstract][Full Text] [Related]
4. [Primary sclerosing cholangitis : Current diagnostics and treatment].
Liwinski T; Schramm C
Internist (Berl); 2018 Jun; 59(6):551-559. PubMed ID: 29700559
[TBL] [Abstract][Full Text] [Related]
5. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
6. [A contribution to the differential diagnostics of sclerosing cholangitides].
Blaho M; Dítě P; Bojková M; Rydlo M; Kupka T; Svoboda P; Klvaňa P; Martínek A
Vnitr Lek; 2017; 63(1):50-55. PubMed ID: 28225291
[TBL] [Abstract][Full Text] [Related]
7. Protective potential of the gallbladder in primary sclerosing cholangitis.
Cazzagon N; Gonzalez-Sanchez E; El-Mourabit H; Wendum D; Rainteau D; Humbert L; Corpechot C; Chazouillères O; Arrivé L; Housset C; Lemoinne S
JHEP Rep; 2023 Apr; 5(4):100649. PubMed ID: 36923239
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study.
Schregel I; Ramos GP; Ioannou S; Culver E; Färkkilä M; Schramm C;
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3448-3450.e3. PubMed ID: 36731589
[No Abstract] [Full Text] [Related]
9. Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis.
Grigoriadis A; Imeen Ringe K; Bengtsson J; Baubeta E; Forsman C; Korsavidou-Hult N; Rorsman F; Nilsson E; Kartalis N; Bergquist A
JHEP Rep; 2022 Dec; 4(12):100595. PubMed ID: 36444388
[TBL] [Abstract][Full Text] [Related]
10. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
[TBL] [Abstract][Full Text] [Related]
11. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis.
Cristoferi L; Porta M; Bernasconi DP; Leonardi F; Gerussi A; Mulinacci G; Palermo A; Gallo C; Scaravaglio M; Stucchi E; Maino C; Ippolito D; D'Amato D; Ferreira C; Nardi A; Banerjee R; Valsecchi MG; Antolini L; Corso R; Sironi S; Fagiuoli S; Invernizzi P; Carbone M
Dig Liver Dis; 2023 Mar; 55(3):373-380. PubMed ID: 36357293
[TBL] [Abstract][Full Text] [Related]
12. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.
Cazzagon N; El Mouhadi S; Vanderbecq Q; Ferreira C; Finnegan S; Lemoinne S; Corpechot C; Chazouillères O; Arrivé L
JHEP Rep; 2022 Nov; 4(11):100577. PubMed ID: 36277957
[TBL] [Abstract][Full Text] [Related]
13. Survey uncovering variations in the management of primary sclerosing cholangitis across Europe.
Eliasson J; Lo B; Schramm C; Chazouilleres O; Folseraas T; Beuers U; Ytting H
JHEP Rep; 2022 Nov; 4(11):100553. PubMed ID: 36164416
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
